Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Transplantation
Volume 2017, Article ID 2426859, 3 pages
https://doi.org/10.1155/2017/2426859
Case Report

Angiosarcoma Developing in an Arteriovenous Fistula after Kidney Transplantation

1Department of Nephrology, Xerencia de Xestión Integrada A Coruña, A Coruña, Spain
2Department of Pathological Anatomy, Xerencia de Xestión Integrada A Coruña, A Coruña, Spain

Correspondence should be addressed to Bruna Natacha Leite Costa; moc.liamtoh@atsoc.ahcatan

Received 5 April 2017; Revised 5 June 2017; Accepted 2 July 2017; Published 6 August 2017

Academic Editor: Mohammed Rafique Moosa

Copyright © 2017 Bruna Natacha Leite Costa et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. A. Wolfe, V. B. Ashby, E. L. Milford et al., “Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant,” The New England Journal of Medicine, vol. 341, no. 23, pp. 1725–1730, 1999. View at Publisher · View at Google Scholar · View at Scopus
  2. OPTN & SRTR Annual data report 2012.
  3. S. A. Lodhi and H.-U. Meier-Kriesche, “Kidney allograft survival: the long and short of it,” Nephrology Dialysis Transplantation, vol. 26, no. 1, pp. 15–17, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. J. R. Chapman, P. J. O'Connell, and B. J. Nankivell, “Chronic renal allograft dysfunction,” Journal of the American Society of Nephrology, vol. 16, no. 10, pp. 3015–3026, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. Z. M. El-Zoghby, M. D. Stegall, D. J. Lager et al., “Identifying specific causes of kidney allograft loss,” American Journal of Transplantation, vol. 9, no. 3, pp. 527–535, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. E. A. Engels, R. M. Pfeiffer, and J. F. Fraumeni Jr., “Spectrum of cancer risk among US solid organ transplant recipients,” The Journal of the American Medical Association, vol. 306, no. 17, pp. 1891–1901, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. R. Navuluri and S. Regalado, “The KDOQI 2006 vascular access update and fistula first program synopsis,” Seminars in Interventional Radiology, vol. 26, no. 2, pp. 122–124, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. H. C. Yaffe and S. M. Greenstein, “Should functioning AV fistulas be ligated after renal transplantation?” The journal of vascular access, vol. 13, no. 4, pp. 405–408, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. E. C. Hall, R. M. Pfeiffer, D. L. Segev, and E. A. Engels, “Cumulative incidence of cancer after solid organ transplantation,” Cancer, vol. 119, no. 12, pp. 2300–2308, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. W. S. Asch and M. J. Bia, “Oncologic issues and kidney transplantation: a review of frequency, mortality, and screening,” Advances in Chronic Kidney Disease, vol. 21, no. 1, pp. 106–113, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. J. D. Briggs, “Causes of death after renal transplantation,” Nephrology Dialysis Transplantation, vol. 16, no. 8, pp. 1545–1549, 2001. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. A. Qureshi, D. C. Strauss, K. Thway, C. Fisher, and J. M. Thomas, “Angiosarcoma developing in a non-functioning arteriovenous fistula post-renal transplant,” Journal of Surgical Oncology, vol. 101, no. 6, pp. 520–523, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. M. van Glabbeke, A. T. van Oosterom, J. W. Oosterhuis et al., “Prognostic factors for the outcome of chemotherapy in advanced soft tissue sarcoma: an analysis of 2,185 patients treated with anthracycline-containing first-line regimens—a European organization for research and treatment of cancer soft tissue and bone sarcoma group study,” Journal of Clinical Oncology, vol. 17, no. 1, pp. 150–157, 1999. View at Publisher · View at Google Scholar · View at Scopus
  14. N. Naka, M. Ohsawa, Y. Tomita, H. Kanno, A. Uchida, and K. Aozasa, “Angiosarcoma in Japan: a review of 99 cases,” Cancer, vol. 75, no. 4, pp. 989–996, 1995. View at Google Scholar · View at Scopus
  15. R. C. Ramanathan, R. A'Hern, C. Fisher, and J. M. Thomas, “Modified staging system for extremity soft tissue sarcomas,” Annals of Surgical Oncology, vol. 6, no. 1, pp. 57–69, 1999. View at Publisher · View at Google Scholar · View at Scopus
  16. G. K. Zagars, M. T. Ballo, P. W. T. Pisters et al., “Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy: an analysis of 1225 patients,” Cancer, vol. 97, no. 10, pp. 2530–2543, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. K. M. Skubitz and P. A. Haddad, “Paclitaxel and pegylated-liposomal doxorubicin are both active in angiosarcoma,” Cancer, vol. 104, no. 2, pp. 361–366, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. R. J. Young, N. J. Brown, M. W. Reed, D. Hughes, and P. J. Woll, “Angiosarcoma,” The Lancet Oncology, vol. 11, no. 10, pp. 983–991, 2010. View at Publisher · View at Google Scholar · View at Scopus